𝛼SK or Searchbullish
Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.
SUMMARY
- RHB sees Raffles Medical's 52-week low as a buying opportunity.
- Citi starts 'buy/high risk' rating on SMID global leader CSE Global.
- Maybank's Seet is bullish on Frencken, lowers target price after $100M placement.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
- Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.10 Sep 2026
x